BCYC today
$3.69+$0.00 (+0.00%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourStrong Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns up above $4.51
Key levels
Resistance$4.13
Resistance$3.80
Support$3.58
Support$3.33
Latest news & SEC filings
EarningsBicycle Therapeutics Posts Q3 2026 Results, Notes Business Progress
EarningsBicycle Therapeutics posts smaller Q3 loss, revenue tops forecast
All BCYC news →About Bicycle Therapeutics
Bicycle Therapeutics is a drug developer working on a class of medicines built from small engineered peptides that fold into two loops, which it designs to bind disease targets with precision. Its own programs center on cancer, including treatments that attach toxins or radioisotopes to these peptides, plus imaging agents and immune-activating compounds. It also partners with other drugmakers to apply its molecule-discovery technology to conditions outside cancer. The company is based in the United Kingdom and the United States.
Based on the company's 10-K filed Mar 17, 2026.
Nasdaq · Healthcare
BICYCLE THERAPEUTICS PLC (BCYC)
What Is the Price Target for BCYC?
SEPT Low Target
$11.05
SEPT Mid Target
$13.00
SEPT High Target
$14.95
Analyst Consensus
$13.00
Is BCYC a Buy or Sell Right Now?
Thesis
- •Revenue growing 105.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BCYC.
Start Free Trial →Is BCYC Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$13.00
27
Moat Score
NONE
2/9
Piotroski Score
-0.3
Altman Z-Score
What Is Smart Money Doing with BCYC?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Perry Jennifer Scott | officer | Sale | 80 | $284.80 | Oct 5, 2026 |
| Perry Jennifer Scott | officer | Sale | 326 | $1K | Oct 5, 2026 |
| Hannay Michael Charles Ferguson | officer | Sale | 242 | $863.94 | Oct 5, 2026 |
| Thompson Travis Alvin | officer | Sale | 79 | $282.03 | Oct 5, 2026 |
| Lee Kevin | director officer | Sale | 1,638 | $6K | Oct 5, 2026 |
| Skynner Michael | officer | Sale | 503 | $2K | Oct 5, 2026 |
| Perry Jennifer Scott | officer | Sale | 30 | $107.10 | Oct 5, 2026 |
| Perry Jennifer Scott | officer | Sale | 1,094 | $4K | Oct 2, 2026 |
| Swanton Robert Charles | director | Sale | 3,431 | $12K | Oct 2, 2026 |
| Hannay Michael Charles Ferguson | officer | Sale | 1,572 | $5K | Oct 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BCYC Growth Story
Revenue YoY
105.8%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-8.97%
FCF Growth YoY
-51.9%
Revenue Trend
ACCELERATING
Dark Pool Trades for BCYC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BCYC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:03:26 | $3.70 | 1,896 | $$7K | BUY |
| 17:19:05 | $3.69 | 1,216 | $$4K | SELL |
| 17:12:04 | $3.69 | 3,800 | $$14K | SELL |
| 17:00:10 | $3.71 | 5,600 | $$21K | MIDPOINT |
| 17:00:10 | $3.71 | 1,400 | $$5K | MIDPOINT |
5 dark pool trades shown · $$51K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for BCYC
PREVIEWSEPT Investing provides real-time options flow tracking for BCYC, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Dec 18 | 37 | $$10 | 1 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$10 | 1 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$10 | 1 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$10 | 1 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$10 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BICYCLE THERAPEUTICS PLC (BCYC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BCYC — frequently asked questions
What is BCYC stock price today?
BICYCLE THERAPEUTICS PLC (BCYC) is at $3.69, up 0.00% (+$0.00) at the Nov 11, 2026 close.
Why is BCYC stock moving today?
Latest BCYC news — Oct 29, 2026: Bicycle Therapeutics Posts Q3 2026 Results, Notes Business Progress · Oct 29, 2026: Bicycle Therapeutics posts smaller Q3 loss, revenue tops forecast
What is the BCYC price target?
The average analyst price target for BCYC is $13.00, ranging from $12 to $14, based on 2 analysts. Latest: Needham maintains on Jul 30, 2026.
What do analysts rate BCYC?
Analyst ratings for BCYC: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did BCYC beat earnings?
BCYC last reported on Jul 30, 2026: EPS -$0.72 vs -$0.56 expected — a miss of 27.6%.
Does BCYC pay a dividend?
BCYC does not currently pay a dividend.
What are BCYC support and resistance levels?
Support: $3.58, $3.33. Resistance: $3.80, $4.13, $4.51.
What are insiders doing with BCYC?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on BCYC?
Oct 29, 2026: Bicycle Therapeutics Posts Q3 2026 Results, Notes Business Progress · Oct 29, 2026: Bicycle Therapeutics posts smaller Q3 loss, revenue tops forecast